Oral vaccination against bovine tuberculosis with Mycobacterium bovis BCG

References

• Orme I. Adaptive immunity to mycobacteria. Curr. Opin. Microbiol.7(1), 58–61 (2004).
   PubMed Web of Science ®Google Scholar
• McMurray DN. Determinants of vaccine-induced resistance in animal models of pulmonary tuberculosis. Scand. J. Infect. Dis.33(3), 175–178 (2001).
   PubMed Web of Science ®Google Scholar
• Franco-Paredes C, Rouphael N, del Rio C et al. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates. Int. J. Infect. Dis.10(2), 93–102 (2006).
   PubMed Web of Science ®Google Scholar
• Martin C. Tuberculosis vaccines: past, present and future. Curr. Opin. Pulm. Med.12(3), 186–191 (2006).
   PubMed Web of Science ®Google Scholar
• Orme IM. Current progress in tuberculosis vaccine development. Vaccine23(17–18), 2105–2108 (2005).
   PubMed Web of Science ®Google Scholar
• McMurray DN. Disease model: pulmonary tuberculosis. Trends Mol. Med.7(3), 135–137 (2001).
   PubMed Web of Science ®Google Scholar
• Ravoglione MC, Snider DE, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a world-wide epidemic. JAMA273, 220–226 (1995).
   PubMed Web of Science ®Google Scholar
• Bannon MJ. BCG and tuberculosis. Arch. Dis. Child.80(1), 80–83 (1999).
   PubMed Web of Science ®Google Scholar
• Hoft DF, Brown RM, Belshe RB. Mucosal bacille Calmette–Guerin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-γ responses. Clin. Infect. Dis.30(Suppl. 3), S217–S222 (2000).
   PubMed Web of Science ®Google Scholar
• Cosgrove CA, Castello-Branco LR, Hussell T et al. Boosting of cellular immunity against Mycobacterium tuberculosis and modulation of skin cytokine responses in healthy human volunteers by Mycobacterium bovis BCG substrain Moreau Rio de Janeiro oral vaccine. Infect. Immun.74(4), 2449–2452 (2006).
   PubMed Web of Science ®Google Scholar
• Haile M, Schroder U, Hamasur B et al. Immunization with heat-killed Mycobacterium bovis bacille Calmette–Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis. Vaccine22(11–12), 1498–1508 (2004).
   PubMed Web of Science ®Google Scholar
• Griffin JFT. Veterinary tuberculosis vaccine development. Clin. Infect. Dis.30(Suppl 3), S223–S228 (2000).
   PubMed Web of Science ®Google Scholar
• Suazo FM, Escalera AM, Torres RM. A review of M. bovis BCG protection against TB in cattle and other animal species. Prev. Vet. Med.58(1–2), 1–13 (2003).
   PubMed Web of Science ®Google Scholar
• Rupprecht CE, Hanlon CA, Slate D. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control. Dev. Biol. (Basel)119, 173–184 (2004).
   PubMedGoogle Scholar
• Brochier B, Aubert MF, Pastoret PP et al. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. Rev. Sci. Tech.15(3), 947–970 (1996).
   PubMed Web of Science ®Google Scholar
• Qureshi T, Labes RE, Cross ML et al. Partial protection against oral challenge with Mycobacterium bovis in ferrets (Mustela furo) following oral vaccination with BCG. Int. J. Tuberc. Lung Dis.3(11), 1025–1033 (1999).
   PubMed Web of Science ®Google Scholar
• Olsen AW, Brandt L, Agger EM et al. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Scand. J. Immunol.60(3), 273–277 (2004).
   PubMed Web of Science ®Google Scholar
• Lagranderie M, Chavarot P, Balazuc AM et al. Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice. Vaccine18(13), 1186–1195 (2000).
   PubMed Web of Science ®Google Scholar
• Gunn JS. Mechanisms of bacterial resistance and response to bile. Microbes Infect.2(8), 907–913 (2000).
   PubMed Web of Science ®Google Scholar
• Skinner MA, Keen DL, Parlane NA et al. Improving protective efficacy of BCG vaccination for wildlife against bovine tuberculosis. Res. Vet. Sci.78(3), 231–236 (2005).
   PubMed Web of Science ®Google Scholar
• Buddle BM, Aldwell FE, Keen DL et al. Intraduodenal vaccination of brushtail possums with bacille Calmette–Guerin enhances immune responses and protection against Mycobacterium bovis infection. Int. J. Tuberc. Lung Dis.1(4), 377–383 (1997).
   PubMed Web of Science ®Google Scholar
• Lagranderie MR, Balazuc AM, Deriaud E et al. Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains. Infect. Immun.64(1), 1–9 (1996).
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Tucker IG, de Lisle GW et al. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect. Immun.71(1), 101–108 (2003).
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Baird MA, Fitzpatrick CE et al. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: anatomical sites of bacterial replication and immune activity. Immunol. Cell. Biol.83(5), 549–553 (2005).
   PubMed Web of Science ®Google Scholar
• Wedlock DN, Aldwell FE, Keen D et al. Oral vaccination of brushtail possums (Trichosurus vulpecula) with BCG: immune responses, persistence of BCG in lymphoid organs and excretion in faeces. NZ Vet. J.53(5), 301–306 (2005).
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Cross ML, Fitzpatrick CE et al. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis. Vaccine24(12), 2071–2078 (2006).
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Brandt L, Fitzpatrick C et al. Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis. Infect. Immun.73(3), 1903–1905 (2005).
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Keen DL, Parlane NA. Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums. Vaccine22(1), 70–76 (2003).
   PubMed Web of Science ®Google Scholar
• Buddle BM, Aldwell FE, Skinner MA et al. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine23(27), 3581–3589 (2005).
   PubMed Web of Science ®Google Scholar
• Buddle BM, Aldwell FE, Keen Dl et al. Oral vaccination of brushtail possums with BCG: investigation into factors that may influence vaccine efficacy and determination of duration of protection. NZ Vet. J.54(5), 224–230 (2006).
   PubMed Web of Science ®Google Scholar
• Doherty TM, Olsen AW, van Pinxteren L et al. Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis. Infect. Immun.70(6), 3111–3121 (2002).
   PubMed Web of Science ®Google Scholar
• Cross ML, Lambeth MR, Coughlan Y et al. Oral vaccination of mice with lipid-encapsulated Mycobacterium bovis BCG: effect of reducing or eliminating BCG load on cell-mediated immunity. Vaccine25(7), 1297–1303 (2007).
   PubMed Web of Science ®Google Scholar
• Palendira U, Bean AG, Feng CG et al. Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization. Infect. Immun.70(3), 1410–1416 (2002).
   PubMed Web of Science ®Google Scholar
• Dorer DE, Lambeth MR, Reitinger C et al. Lymphatic tracing of vaccine and T cell responses following oral vaccination with Mycobacterium bovis (BCG). Tissue Antigens66(5), 491–492 (2005).
   Google Scholar
• Dorer DE, Czepluch W, Lambeth MR et al. Lymphatic tracing and T cell responses following oral vaccination with live Mycobacterium bovis (BCG). Cell. Microbiol.9(2), 544–553 (2007).
   PubMed Web of Science ®Google Scholar
• Kipnis A, Irwin S, Izzo AA et al. Memory T lymphocytes generated by Mycobacterium bovis BCG vaccination reside within a CD4 CD44lo / CD62 Ligandhi population. Infect. Immun.73(11), 7759–7764 (2005).
   PubMed Web of Science ®Google Scholar
• Corner LA, Norton S, Buddle BM et al. The efficacy of bacille Calmette–Guerin vaccine in wild brushtail possums (Trichosurus vulpecula). Res. Vet. Sci.73(2), 145–152 (2002).
   PubMed Web of Science ®Google Scholar
• Corner LA, Buddle BM, Pfeiffer DU et al. Aerosol vaccination of the brushtail possum (Trichosurus vulpecula) with bacille Calmette–Guerin: the duration of protection. Vet. Microbiol.81(2), 181–191 (2001).
   PubMed Web of Science ®Google Scholar
• Manabe YC, Scott CP, Bishai WR. Naturally attenuated, orally administered Mycobacterium microti as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG. Infect. Immun.70(3), 1566–1570 (2002).
   PubMed Web of Science ®Google Scholar
• Hotter GS, Wards BJ, Mouat P et al. Transposon mutagenesis of Mb0100 at the ppe1-nrp locus in Mycobacterium bovis disrupts phthiocerol dimycocerosate (PDIM) and glycosylphenol-PDIM biosynthesis, producing an avirulent strain with vaccine properties at least equal to those of M. bovis BCG. J. Bacteriol.187(7), 2267–2277 (2005).
   PubMed Web of Science ®Google Scholar
• Martin C. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Eur. Respir. J.26(1), 162–167 (2005).
   PubMed Web of Science ®Google Scholar
• Dietrich J, Weldingh K, Andersen P. Prospects for a novel vaccine against tuberculosis. Vet. Microbiol.112(2–4), 163–169 (2006).
   PubMed Web of Science ®Google Scholar
• Benevolo-de-Andrade TC, Monteiro-Maia R, Cosgrove C et al. BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis – a review. Mem. Inst. Oswaldo Cruz.100(5), 459–465 (2005).
   PubMed Web of Science ®Google Scholar
• Dobakhti F, Rahimi F, Dehpour AR et al. Stabilizing effects of calcium alginate microspheres on Mycobacterium bovis BCG intended for oral vaccination. J. Microencapsul.23(8), 844–854 (2006).
   PubMed Web of Science ®Google Scholar
• McCluskie MJ, Weeratna RD, Payette PJ et al. The potential of oligodeoxynucleotides as mucosal adjuvants. Crit. Rev. Immunol.21(1–3), 103–120 (2001).
   PubMed Web of Science ®Google Scholar
• George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan – a review. J. Control Release114(1), 1–14 (2006).
   PubMed Web of Science ®Google Scholar
• Roy K, Mao HQ, Huang SK et al. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med.5(4), 387–391 (1999).
   PubMed Web of Science ®Google Scholar
• Huang J, Garmise RJ, Crowder TM et al. A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. Vaccine23(6), 794–801 (2004).
   PubMed Web of Science ®Google Scholar
• de Lisle GW, Wards BJ, Buddle BM et al. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium. Tuberculosis (Edinb.)85(1–2), 73–79 (2005).
   PubMed Web of Science ®Google Scholar
• Flaherty DK, Vesosky B, Beamer GL et al. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. J. Leukoc. Biol.80(6), 1262–1271 (2006).
   PubMed Web of Science ®Google Scholar
• Southey A, Sleeman DP, Lloyd K et al. Immunological responses of Eurasian badgers (Meles meles) vaccinated with Mycobacterium bovis BCG (bacillus Calmette Guerin). Vet. Immunol. Immunopathol.79(3–4), 197–207 (2001).
   PubMed Web of Science ®Google Scholar
• Lesellier S, Palmer S, Dalley DJ et al. The safety and immunogenicity of bacillus Calmette–Guerin (BCG) vaccine in European badgers (Meles meles). Vet. Immunol. Immunopathol.112(1–2), 24–37 (2006).
   PubMed Web of Science ®Google Scholar
• Aldwell FE, Keen DL, Stent VC et al. Route of BCG administration in possums affects protection against bovine tuberculosis. NZ Vet. J.43(7), 356–359 (1995).
   PubMed Web of Science ®Google Scholar